Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-30T21:32:31.505Z Has data issue: false hasContentIssue false
  • English
  • Français

A New Effect of Acetylsalicylic Acid? Significantly Lower Prevalence of Nasal Carriage of Staphylococcus aureus Among Patients Receiving Orally Administered Acetylsalicylic Acid

Published online by Cambridge University Press:  21 June 2016

Oguz Karabay ,
Huseyin Arinc ,
Hüseyin Gunduz ,
Ali Tamer ,
Hakan Ozhan  and
Cihangir Uyan
Oguz Karabay*
Affiliation:
Department of Infectious Diseases and Clinical Microbiology, Izzet Baysal Medical Faculty, University of Abant Izzet Baysal, Golkoy, Bolu, Turkey
Huseyin Arinc
Affiliation:
Department of Cardiology, Izzet Baysal Medical Faculty, University of Abant Izzet Baysal, Golkoy, Bolu, Turkey
Hüseyin Gunduz
Affiliation:
Department of Cardiology, Izzet Baysal Medical Faculty, University of Abant Izzet Baysal, Golkoy, Bolu, Turkey
Ali Tamer
Affiliation:
Department of Internal Medicine, Izzet Baysal Medical Faculty, University of Abant Izzet Baysal, Golkoy, Bolu, Turkey
Hakan Ozhan
Affiliation:
Department of Cardiology, Duzce Medical Faculty, University of Abant Izzet Baysal, Konuralp, Duzce, Turkey
Cihangir Uyan
Affiliation:
Department of Cardiology, Izzet Baysal Medical Faculty, University of Abant Izzet Baysal, Golkoy, Bolu, Turkey
*
Abant Izzet Baysal University, Izzet Baysal Medical Faculty, Department of Infectious Diseases and Clinical Microbiology, Golkoy, 14100 Bolu, Turkey ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

We aimed to evaluate effect of acetylsalicylic acid on the prevalence of nasal carriage of Staphylococcus aureus. Patients were orally administered a prophylactic dose of acetylsalicylic acid and then were compared with control subjects. The prevalence of nasal carriage of S. aureus was significantly lower among patients who received acetylsalicylic acid than among the control subjects (P<.001).

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 27 , Issue 3 , March 2006 , pp. 318 - 319
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Parkin, JD. The enigma of aspirin. Aust N Z J Med 1987; 17:192–194.CrossRefGoogle ScholarPubMed
2.Herrmann, M. Salicylic acid: an old dog, new tricks, and staphylococcal disease. J Clin Invest 2003; 112:149–151.CrossRefGoogle ScholarPubMed
3.Lee, LY, Hook, M, Haviland, D, et al. Inhibition of complement activation by a secreted Staphylococcus aureus protein. J Infect Dis 2004; 190:571–579.CrossRefGoogle ScholarPubMed
4.Nicolau, DP, Freeman, CD, Nightingale, CH, et al. Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis. Infect Immun 1993;61:1593–1595.CrossRefGoogle ScholarPubMed
5.Kupferwasser, LI, Yeaman, MR, Nast, CC, et al. Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus. J Clin Invest 2003; 112:222–233.CrossRefGoogle ScholarPubMed
6.Peacock, SJ, Justice, A, Griffiths, D, et al. Determinants of acquisition and carriage of Staphylococcus aureus in infancy. J Clin Microbiol 2003; 41:5718–5725.CrossRefGoogle ScholarPubMed
7.Falanga, V, Campbell, DE, Leyden, JJ, Douglas, SD. Nasal carriage of Staphylococcus aureus and antistaphylococcal immunoglobulin E antibodies in atopic dermatitis. J Clin Microbiol 1985; 22:452–454.CrossRefGoogle ScholarPubMed
8.Bartzokas, CA, Paton, JH, Gibson, MF, Graham, F, McLoughlin, GA, Croton, RS. Control and eradication of methicillin-resistant Staphylococcus aureus on a surgical unit. N Engl J Med 1984; 311:1422–1425.CrossRefGoogle ScholarPubMed
9.Cole, AM, Tahk, S, Oren, A, Yoshioka, D, Kim, YH, Park, A, Ganz, T. Determinants of Staphylococcus aureus nasal carriage. Clin Diagn Lab Immunol 2001; 8:1064–1069.CrossRefGoogle ScholarPubMed
10.Gernaat-van der Sluis, AJ, Hoogenboom-Verdegaal, AM, Edixhoven, PJ, Spies-van Rooijen, NH. Prophylactic mupirocin could reduce orthopedic wound infections: 1,044 patients treated with mupirocin compared with 1,260 historical controls. Acta Orthop Scand 1998;69:412–414.CrossRefGoogle Scholar